DIREXION SHS ETF TR's ticker is CURE and the CUSIP is 25459Y876. A total of 21 filers reported holding DIREXION SHS ETF TR in Q3 2023. The put-call ratio across all filers is 2.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 55,597 | $2,523,000 | 0.14% |
| Traynor Capital Management, Inc. | 7,481 | $341,000 | 0.12% |
| Virtu Financial LLC | 49,149 | $2,230,000 | 0.10% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 2,436 | $111,000 | 0.08% |
| Capital Analysts, LLC | 6,000 | $272,000 | 0.03% |
| Acorn Wealth Advisors, LLC | 395 | $18,000 | 0.02% |
| BANQUE PICTET & CIE SA | 10,120 | $459,000 | 0.01% |
| Citadel Advisors | 78,471 | $3,560,000 | 0.00% |
| WOLVERINE TRADING, LLC | 22,300 | $960,000 | 0.00% |
| JANE STREET GROUP, LLC | 21,346 | $968,000 | 0.00% |